Danish guidelines on importers/manufacturers:
This article was originally published in Clinica
The Danish Medicines Agency has published guidelines that clarify when an importer becomes a manufacturer, the Danish manufacturers association MedicoIndustrien reports. These guidelines reflect EU policy, so that if an importer or parallel distributor were to move into the manufacturer's field of responsibility, for example by modifying a product of its packing, they would assume full responsibility as the manufacturer. If however, changes involve inserting a Danish translation of the manufacturer's original instructions for use, or adding an additional label to the package to conform to the Danish language requirements, then the importer or distributor would not be regarded as taking on the manufacturer's responsibilities. For further information see: http://www.medicinskudstyr.dk/1024/visNyhed.mu.asp?artikelID=5692
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.